File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.3109/00365548.2010.490562
- Scopus: eid_2-s2.0-77956819449
- PMID: 20524786
- WOS: WOS:000282987100006
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Epidemiology and clinical features of Shewanella infection over an eight-year period
Title | Epidemiology and clinical features of Shewanella infection over an eight-year period |
---|---|
Authors | |
Issue Date | 2010 |
Publisher | Informa Healthcare. The Journal's web site is located at http://www.tandf.co.uk/journals/titles/00365548.asp |
Citation | Scandinavian Journal Of Infectious Diseases, 2010, v. 42 n. 10, p. 757-762 How to Cite? |
Abstract | Shewanella is a rare human pathogen that can lead to fatal infections. However, clinical information about this bacterium remains scarce. In this study, we retrospectively reviewed all patients with laboratory isolates of Shewanella over an 8-y period to assess risk factors, clinical manifestations and outcome. Twenty-nine patients were identified. Shewanella was most commonly isolated from intra-abdominal specimens (48.2%), followed by skin and soft tissue specimens (27.6%), blood (13.8%) and sputum (10.3%). Malignancy, hepatobiliary disease and diabetes mellitus were common underlying diseases. The overall 30-day mortality rate was 20.6%. Shewanella was considered a definite causative pathogen in 7 patients, and a recurrent infection occurred in 2 patients. Colonization of the biliary tract was common. Among co-isolated pathogens, the enteric flora was most represented. All isolates were susceptible to ceftazidime and aminoglycosides, but 1 isolate was resistant to imipenem. In conclusion, Shewanella may become a colonizing bacterium, subsequently causing invasive diseases in patients with an underlying disease. © 2010 Informa Healthcare. |
Persistent Identifier | http://hdl.handle.net/10722/130631 |
ISSN | 2016 Impact Factor: 2.201 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | To, KKW | en_HK |
dc.contributor.author | Wong, SSY | en_HK |
dc.contributor.author | Cheng, VCC | en_HK |
dc.contributor.author | Tang, BSF | en_HK |
dc.contributor.author | Li, IWS | en_HK |
dc.contributor.author | Chan, JFW | en_HK |
dc.contributor.author | Seto, WK | en_HK |
dc.contributor.author | Tse, H | en_HK |
dc.contributor.author | Yuen, KY | en_HK |
dc.date.accessioned | 2010-12-23T10:31:28Z | - |
dc.date.available | 2010-12-23T10:31:28Z | - |
dc.date.issued | 2010 | en_HK |
dc.identifier.citation | Scandinavian Journal Of Infectious Diseases, 2010, v. 42 n. 10, p. 757-762 | en_HK |
dc.identifier.issn | 0036-5548 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/130631 | - |
dc.description.abstract | Shewanella is a rare human pathogen that can lead to fatal infections. However, clinical information about this bacterium remains scarce. In this study, we retrospectively reviewed all patients with laboratory isolates of Shewanella over an 8-y period to assess risk factors, clinical manifestations and outcome. Twenty-nine patients were identified. Shewanella was most commonly isolated from intra-abdominal specimens (48.2%), followed by skin and soft tissue specimens (27.6%), blood (13.8%) and sputum (10.3%). Malignancy, hepatobiliary disease and diabetes mellitus were common underlying diseases. The overall 30-day mortality rate was 20.6%. Shewanella was considered a definite causative pathogen in 7 patients, and a recurrent infection occurred in 2 patients. Colonization of the biliary tract was common. Among co-isolated pathogens, the enteric flora was most represented. All isolates were susceptible to ceftazidime and aminoglycosides, but 1 isolate was resistant to imipenem. In conclusion, Shewanella may become a colonizing bacterium, subsequently causing invasive diseases in patients with an underlying disease. © 2010 Informa Healthcare. | en_HK |
dc.language | eng | en_US |
dc.publisher | Informa Healthcare. The Journal's web site is located at http://www.tandf.co.uk/journals/titles/00365548.asp | en_HK |
dc.relation.ispartof | Scandinavian Journal of Infectious Diseases | en_HK |
dc.subject.mesh | Adult | en_HK |
dc.subject.mesh | Aged | en_HK |
dc.subject.mesh | Aged, 80 and over | en_HK |
dc.subject.mesh | Anti-Bacterial Agents - pharmacology | en_HK |
dc.subject.mesh | Female | en_HK |
dc.subject.mesh | Gram-Positive Bacterial Infections - epidemiology - microbiology - mortality - physiopathology | en_HK |
dc.subject.mesh | Hong Kong - epidemiology | en_HK |
dc.subject.mesh | Humans | en_HK |
dc.subject.mesh | Male | en_HK |
dc.subject.mesh | Microbial Sensitivity Tests | en_HK |
dc.subject.mesh | Middle Aged | en_HK |
dc.subject.mesh | Prognosis | en_HK |
dc.subject.mesh | Retrospective Studies | en_HK |
dc.subject.mesh | Risk Factors | en_HK |
dc.subject.mesh | Shewanella - classification - drug effects - isolation & purification - pathogenicity | en_HK |
dc.title | Epidemiology and clinical features of Shewanella infection over an eight-year period | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | To, KKW: kelvinto@hkucc.hku.hk | en_HK |
dc.identifier.email | Wong, SSY: samsonsy@hkucc.hku.hk | en_HK |
dc.identifier.email | Chan, JFW: jfwchan@hku.hk | en_HK |
dc.identifier.email | Seto, WK: wkseto2@hku.hk | en_HK |
dc.identifier.email | Tse, H: htse@hkucc.hku.hk | en_HK |
dc.identifier.email | Yuen, KY: kyyuen@hkucc.hku.hk | en_HK |
dc.identifier.authority | To, KKW=rp01384 | en_HK |
dc.identifier.authority | Wong, SSY=rp00395 | en_HK |
dc.identifier.authority | Chan, JFW=rp01736 | en_HK |
dc.identifier.authority | Seto, WK=rp01659 | en_HK |
dc.identifier.authority | Tse, H=rp00519 | en_HK |
dc.identifier.authority | Yuen, KY=rp00366 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.3109/00365548.2010.490562 | en_HK |
dc.identifier.pmid | 20524786 | - |
dc.identifier.scopus | eid_2-s2.0-77956819449 | en_HK |
dc.identifier.hkuros | 178247 | en_US |
dc.identifier.hkuros | 213670 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-77956819449&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 42 | en_HK |
dc.identifier.issue | 10 | en_HK |
dc.identifier.spage | 757 | en_HK |
dc.identifier.epage | 762 | en_HK |
dc.identifier.isi | WOS:000282987100006 | - |
dc.publisher.place | United Kingdom | en_HK |
dc.identifier.scopusauthorid | To, KKW=14323807300 | en_HK |
dc.identifier.scopusauthorid | Wong, SSY=13310021400 | en_HK |
dc.identifier.scopusauthorid | Cheng, VCC=23670479400 | en_HK |
dc.identifier.scopusauthorid | Tang, BSF=8908243000 | en_HK |
dc.identifier.scopusauthorid | Li, IWS=24464179500 | en_HK |
dc.identifier.scopusauthorid | Chan, JFW=24278817900 | en_HK |
dc.identifier.scopusauthorid | Seto, WK=23390675900 | en_HK |
dc.identifier.scopusauthorid | Tse, H=7006070596 | en_HK |
dc.identifier.scopusauthorid | Yuen, KY=36078079100 | en_HK |
dc.identifier.issnl | 0036-5548 | - |